What is Diebold Nixdorf's earnings per share (EPS)?

Diebold Nixdorf (DBD) reported diluted earnings per share of $2.54 for fiscal year 2025. This represents a 677.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Diebold Nixdorf Financials

DBD

Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE December

This page shows Diebold Nixdorf (DBD) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI DBD FY2025 2026-04-22

Debt relief and leaner operating costs turned a nearly flat revenue base into meaningfully better profit and cash generation.

Between FY2022 and FY2025, the real turnaround was financial structure, not sales momentum: long-term debt fell from $2.6B to $938.5M, shrinking the fixed financing burden that had been overwhelming the income statement. That lower financing drag helped net margin swing from -16.8% to 2.5%, even though FY2025 revenue was only modestly above FY2024, so the improvement came from a lighter cost stack rather than a demand surge.

Cash conversion improved faster than reported earnings: FY2025 operating cash flow reached $300.7M while net income was $94.6M, a gap that usually signals noncash charges and tighter working-capital control rather than paper-only profit. With inventory slightly lower and the current ratio still near 1.3x, the business appears to be needing less cash to support day-to-day operations as conditions normalize.

Margin repair came more from cost structure than volume: gross margin moved from 24.5% to 25.3%, and SG&A stayed well below the pre-reset level, so a small sales increase translated into a much larger gain in operating income. The balance sheet also looks fundamentally different, shifting from negative equity in FY2022 to $1.1B positive by FY2025, which means operating setbacks no longer sit on top of the same level of capital strain.

Financial Health Signals

Financial Profile 33/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Diebold Nixdorf's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Diebold Nixdorf has an operating margin of 6.4%, meaning the company retains $6 of operating profit per $100 of revenue. This results in a moderate score of 30/100, indicating healthy but not exceptional operating efficiency. This is up from 4.9% the prior year.

Growth

Diebold Nixdorf's revenue grew a modest 1.5% year-over-year to $3.8B. This slow but positive growth earns a score of 41/100.

Leverage

Diebold Nixdorf carries a low D/E ratio of 0.85, meaning only $0.85 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 85/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

Diebold Nixdorf's current ratio of 1.30 is below the typical benchmark, resulting in a score of 21/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Returns

Diebold Nixdorf generates a 8.6% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 22/100. This is up from -1.8% the prior year.

Altman Z-Score Grey Zone

1.94

Diebold Nixdorf scores 1.94, placing it in the grey zone between 1.81 and 2.99. This signals moderate financial risk that warrants monitoring.

Piotroski F-Score Strong

7/9

Diebold Nixdorf passes 7 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed

3.18x

For every $1 of reported earnings, Diebold Nixdorf generates $3.18 in operating cash flow ($300.7M OCF vs $94.6M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Adequate

3.2x

Diebold Nixdorf earns $3.2 in operating income for every $1 of interest expense ($242.0M vs $76.8M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$3.8B

YoY+1.5%

5Y CAGR-2.9%

10Y CAGR+3.4%

Diebold Nixdorf generated $3.8B in revenue in fiscal year 2025. This represents an increase of 1.5% from the prior year.

EBITDA

$369.5M

YoY+17.5%

5Y CAGR+13.1%

10Y CAGR+4.5%

Diebold Nixdorf's EBITDA was $369.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 17.5% from the prior year.

Net Income

$94.6M

YoY+673.3%

10Y CAGR-1.9%

Diebold Nixdorf reported $94.6M in net income in fiscal year 2025. This represents an increase of 673.3% from the prior year.

EPS (Diluted)

$2.54

YoY+677.3%

10Y CAGR+3.7%

Diebold Nixdorf earned $2.54 per diluted share (EPS) in fiscal year 2025. This represents an increase of 677.3% from the prior year.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$368.9M

YoY+24.5%

5Y CAGR+5.6%

10Y CAGR+1.2%

Diebold Nixdorf held $368.9M in cash against $938.5M in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

35M

YoY-6.4%

5Y CAGR-14.5%

10Y CAGR-5.9%

Diebold Nixdorf had 35M shares outstanding in fiscal year 2025. This represents a decrease of 6.4% from the prior year.

Margins & Returns

Gross Margin

25.3%

YoY+0.7pp

5Y CAGR+1.1pp

10Y CAGR-1.3pp

Diebold Nixdorf's gross margin was 25.3% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 0.7 percentage points from the prior year.

Operating Margin

6.4%

YoY+1.5pp

5Y CAGR+7.0pp

10Y CAGR+0.3pp

Diebold Nixdorf's operating margin was 6.4% in fiscal year 2025, reflecting core business profitability. This is up 1.5 percentage points from the prior year.

Net Margin

2.5%

YoY+2.9pp

5Y CAGR+10.2pp

10Y CAGR-1.7pp

Diebold Nixdorf's net profit margin was 2.5% in fiscal year 2025, showing the share of revenue converted to profit. This is up 2.9 percentage points from the prior year.

Return on Equity

8.6%

YoY+10.4pp

10Y CAGR-12.9pp

Diebold Nixdorf's ROE was 8.6% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 10.4 percentage points from the prior year.

Capital Allocation

R&D Spending

$86.7M

YoY-7.4%

5Y CAGR-10.0%

10Y CAGR-0.8%

Diebold Nixdorf invested $86.7M in research and development in fiscal year 2025. This represents a decrease of 7.4% from the prior year.

Share Buybacks

$130.7M

5Y CAGR+133.1%

10Y CAGR+52.7%

Diebold Nixdorf spent $130.7M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Capital Expenditures

N/A

DBD Income Statement

Metric	FY25	FY24	FY22	FY21	FY20	FY19
Revenue	$3.8B+1.5%	$3.8B+8.4%	$3.5B-11.4%	$3.9B+0.1%	$3.9B-11.5%	$4.4B
Cost of Revenue	$2.8B+0.5%	$2.8B+4.7%	$2.7B-5.5%	$2.9B-0.2%	$2.9B-14.2%	$3.3B
Gross Profit	$961.2M+4.5%	$920.0M+21.5%	$757.3M-27.4%	$1.0B+0.8%	$1.0B-3.0%	$1.1B
R&D Expenses	$86.7M-7.4%	$93.6M-22.5%	$120.7M-4.4%	$126.3M-5.3%	$133.4M-9.3%	$147.1M
SG&A Expenses	$632.5M-1.7%	$643.6M-13.2%	$741.6M-4.4%	$775.6M-9.7%	$858.6M-5.5%	$908.8M
Operating Income	$242.0M+32.9%	$182.1M+186.0%	-$211.7M-254.4%	$137.1M+471.3%	$24.0M+190.2%	-$26.6M
Interest Expense	$76.8M-45.6%	$141.3M-29.1%	$199.2M+2.0%	$195.3M-26.8%	$266.8M+31.5%	$202.9M
Income Tax	$24.1M-62.5%	$64.3M-56.9%	$149.2M+438.6%	$27.7M+2870.0%	-$1.0M-100.9%	$116.7M
Net Income	$94.6M+673.3%	-$16.5M+97.2%	-$581.4M-637.8%	-$78.8M+70.7%	-$269.1M+21.2%	-$341.3M
EPS (Diluted)	$2.54+677.3%	$-0.44+94.0%	$-7.36-628.7%	$-1.01+70.9%	$-3.47	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Revenue	$891.8M-19.2%	$1.1B+16.8%	$945.2M+3.3%	$915.2M+8.8%	$841.1M-14.9%	$988.9M+6.7%	$927.1M-1.3%	$939.7M
Cost of Revenue	$678.7M-17.7%	$824.5M+17.8%	$700.1M+2.8%	$681.2M+6.7%	$638.7M-15.7%	$757.3M+9.7%	$690.5M-0.9%	$696.5M
Gross Profit	$213.1M-23.8%	$279.7M+14.1%	$245.1M+4.7%	$234.0M+15.6%	$202.4M-12.6%	$231.6M-2.1%	$236.6M-2.7%	$243.2M
R&D Expenses	$22.1M+3.8%	$21.3M+4.9%	$20.3M-9.4%	$22.4M-1.3%	$22.7M-5.0%	$23.9M+2.1%	$23.4M+5.9%	$22.1M
SG&A Expenses	$157.2M-10.5%	$175.6M+16.4%	$150.9M-2.1%	$154.2M+1.6%	$151.8M-8.1%	$165.2M+0.4%	$164.6M+8.1%	$152.2M
Operating Income	$32.7M-60.3%	$82.4M+11.7%	$73.8M+31.3%	$56.2M+89.9%	$29.6M-28.2%	$41.2M-11.2%	$46.4M-34.4%	$70.7M
Interest Expense	$23.3M+99.1%	$11.7M-46.3%	$21.8M0.0%	$21.8M+1.4%	$21.5M+3.9%	$20.7M-46.1%	$38.4M-0.5%	$38.6M
Income Tax	$5.7M-52.1%	$11.9M+24.0%	$9.6M+100.0%	$4.8M+318.2%	-$2.2M-140.0%	$5.5M-81.6%	$29.9M-6.6%	$32.0M
Net Income	$5.0M-89.9%	$49.6M+20.7%	$41.1M+236.9%	$12.2M+247.0%	-$8.3M-248.2%	$5.6M+125.0%	-$22.4M-250.3%	$14.9M
EPS (Diluted)	$0.14	N/A	$1.11+236.4%	$0.33+250.0%	$-0.22	N/A	$-0.60-250.0%	$0.40

DBD Balance Sheet

Metric	FY25	FY24	FY22	FY21	FY20	FY19
Total Assets	$3.9B+8.8%	$3.5B+15.6%	$3.1B-12.6%	$3.5B-4.1%	$3.7B-3.5%	$3.8B
Current Assets	$1.8B+7.1%	$1.7B-5.8%	$1.8B-6.2%	$1.9B+1.6%	$1.9B-1.8%	$1.9B
Cash & Equivalents	$368.9M+24.5%	$296.2M-3.6%	$307.4M-21.0%	$388.9M+19.8%	$324.5M+15.5%	$280.9M
Inventory	$521.0M-1.3%	$528.1M-10.2%	$588.1M+8.1%	$544.2M+9.2%	$498.2M+6.8%	$466.5M
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	$642.4M+9.5%	$586.4M-16.5%	$702.3M-5.6%	$743.6M-7.1%	$800.4M+4.8%	$764.0M
Total Liabilities	$2.7B+5.5%	$2.6B-41.3%	$4.4B+1.9%	$4.4B-2.9%	$4.5B+3.8%	$4.3B
Current Liabilities	$1.4B+8.3%	$1.3B-21.1%	$1.6B-8.3%	$1.7B+6.1%	$1.6B+3.1%	$1.6B
Long-Term Debt	$938.5M+1.2%	$927.3M-63.7%	$2.6B+13.9%	$2.2B-3.9%	$2.3B+10.8%	$2.1B
Total Equity	$1.1B+18.3%	$929.8M+167.3%	-$1.4B-63.4%	-$845.1M-2.2%	-$827.1M-56.0%	-$530.3M
Retained Earnings	$91.9M+8454.5%	-$1.1M+99.9%	-$1.4B-71.0%	-$822.4M-10.8%	-$742.3M-57.2%	-$472.3M

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Total Assets	$3.8B-0.6%	$3.9B+3.5%	$3.7B-0.4%	$3.7B+3.2%	$3.6B+2.3%	$3.5B-9.2%	$3.9B+1.3%	$3.8B
Current Assets	$1.8B+0.7%	$1.8B+3.8%	$1.7B-0.9%	$1.7B+0.5%	$1.7B+3.6%	$1.7B-12.2%	$1.9B-0.4%	$1.9B
Cash & Equivalents	$358.6M-2.8%	$368.9M+49.9%	$246.1M-11.9%	$279.2M-8.9%	$306.5M+3.5%	$296.2M+18.0%	$251.1M-9.3%	$276.7M
Inventory	$553.1M+6.2%	$521.0M-13.1%	$599.7M+4.5%	$574.0M+3.8%	$553.0M+4.7%	$528.1M-17.6%	$641.1M+1.3%	$632.7M
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	$632.1M-1.6%	$642.4M0.0%	$642.1M+0.1%	$641.2M+6.2%	$603.9M+3.0%	$586.4M-5.4%	$619.6M+2.9%	$602.4M
Total Liabilities	$2.8B+2.0%	$2.7B+5.3%	$2.6B-0.9%	$2.6B0.0%	$2.6B+1.1%	$2.6B-7.8%	$2.8B-0.5%	$2.8B
Current Liabilities	$1.4B+2.4%	$1.4B+8.6%	$1.3B-0.8%	$1.3B-0.8%	$1.3B+1.4%	$1.3B-3.5%	$1.3B-2.2%	$1.3B
Long-Term Debt	$939.4M+0.1%	$938.5M+0.5%	$934.0M+0.3%	$931.1M+0.3%	$928.7M+0.2%	$927.3M-13.0%	$1.1B0.0%	$1.1B
Total Equity	$1.0B-7.0%	$1.1B-0.7%	$1.1B+0.9%	$1.1B+11.5%	$984.0M+5.8%	$929.8M-12.8%	$1.1B+7.0%	$996.7M
Retained Earnings	$96.9M+5.4%	$91.9M+109.3%	$43.9M+1467.9%	$2.8M+129.8%	-$9.4M-754.5%	-$1.1M+78.0%	-$5.0M-128.7%	$17.4M

DBD Cash Flow Statement

Metric	FY25	FY24	FY22	FY21	FY20	FY19
Operating Cash Flow	$300.7M+101.5%	$149.2M+138.5%	-$387.9M-414.6%	$123.3M+585.0%	$18.0M-86.7%	$135.8M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	-$97.6M-114.5%	-$45.5M-91.2%	-$23.8M+51.6%	-$49.2M+40.4%	-$82.6M-1114.7%	-$6.8M
Financing Cash Flow	-$143.9M+60.7%	-$366.5M-204.8%	$349.8M+9816.7%	-$3.6M-121.3%	$16.9M+107.8%	-$215.5M
Dividends Paid	N/A	N/A	N/A	N/A	$0	$0
Share Buybacks	$130.7M	$0-100.0%	$7.8M+1.3%	$7.7M+16.7%	$6.6M+247.4%	$1.9M

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	$31.7M-85.4%	$217.5M+481.6%	$37.4M+24.3%	$30.1M+91.7%	$15.7M-92.0%	$196.2M+1365.8%	-$15.5M-93.8%	-$8.0M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	$20.2M+152.3%	-$38.6M-47.3%	-$26.2M+20.1%	-$32.8M	$0+100.0%	-$17.3M-39.5%	-$12.4M-663.6%	$2.2M
Financing Cash Flow	-$62.2M-11.7%	-$55.7M-26.3%	-$44.1M-40.9%	-$31.3M-144.5%	-$12.8M+93.3%	-$192.0M-4073.9%	-$4.6M+61.3%	-$11.9M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$60.4M+18.2%	$51.1M+28.1%	$39.9M+32.6%	$30.1M+213.5%	$9.6M	$0	$0	$0

DBD Financial Ratios

Metric	FY25	FY24	FY22	FY21	FY20	FY19
Gross Margin	25.3%+0.7pp	24.5%+2.6pp	21.9%-4.8pp	26.7%+0.2pp	26.5%+2.3pp	24.2%
Operating Margin	6.4%+1.5pp	4.9%+11.0pp	-6.1%-9.6pp	3.5%+2.9pp	0.6%+1.2pp	-0.6%
Net Margin	2.5%+2.9pp	-0.4%+16.4pp	-16.8%-14.8pp	-2.0%+4.9pp	-6.9%+0.8pp	-7.7%
Return on Equity	8.6%+10.4pp	-1.8%	N/A	N/A	N/A	N/A
Return on Assets	2.5%+2.9pp	-0.5%+18.5pp	-19.0%-16.7pp	-2.3%+5.1pp	-7.4%+1.6pp	-9.0%
Current Ratio	1.30-0.0	1.32+0.2	1.10+0.0	1.08-0.0	1.13-0.1	1.18
Debt-to-Equity	0.85-0.1	1.00+2.8	-1.85+0.8	-2.66+0.2	-2.82+1.2	-3.98
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Gross Margin	23.9%-1.4pp	25.3%-0.6pp	25.9%+0.4pp	25.6%+1.5pp	24.1%+0.6pp	23.4%-2.1pp	25.5%-0.4pp	25.9%
Operating Margin	3.7%-3.8pp	7.5%-0.4pp	7.8%+1.7pp	6.1%+2.6pp	3.5%-0.6pp	4.2%-0.8pp	5.0%-2.5pp	7.5%
Net Margin	0.6%-3.9pp	4.5%+0.1pp	4.3%+3.0pp	1.3%+2.3pp	-1.0%-1.6pp	0.6%+3.0pp	-2.4%-4.0pp	1.6%
Return on Equity	0.5%-4.0pp	4.5%+0.8pp	3.7%+2.6pp	1.1%+1.9pp	-0.8%-1.4pp	0.6%+2.7pp	-2.1%-3.6pp	1.5%
Return on Assets	0.1%-1.2pp	1.3%+0.2pp	1.1%+0.8pp	0.3%+0.6pp	-0.2%-0.4pp	0.2%+0.7pp	-0.6%-1.0pp	0.4%
Current Ratio	1.28-0.0	1.30-0.1	1.360.0	1.36+0.0	1.35+0.0	1.32-0.1	1.45+0.0	1.42
Debt-to-Equity	0.92+0.1	0.850.0	0.840.0	0.85-0.1	0.94-0.1	1.000.0	1.00-0.1	1.07
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Similar Companies

Sapiens Interntl SPNS

$2.4B

Alight Inc. ALIT

$426.7M

NCR Atleos Corp NATL

$3.2B

Doubleverify Hldgs Inc DV

$1.8B

Alkami Technology, Inc. ALKT

$1.8B

Frequently Asked Questions

What is Diebold Nixdorf's annual revenue?

Diebold Nixdorf (DBD) reported $3.8B in total revenue for fiscal year 2025. This represents a 1.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Diebold Nixdorf's revenue growing?

Diebold Nixdorf (DBD) revenue grew by 1.5% year-over-year, from $3.8B to $3.8B in fiscal year 2025.

Is Diebold Nixdorf profitable?

Yes, Diebold Nixdorf (DBD) reported a net income of $94.6M in fiscal year 2025, with a net profit margin of 2.5%.

What is Diebold Nixdorf's EBITDA?

Diebold Nixdorf (DBD) had EBITDA of $369.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Diebold Nixdorf have?

As of fiscal year 2025, Diebold Nixdorf (DBD) had $368.9M in cash and equivalents against $938.5M in long-term debt.

What is Diebold Nixdorf's gross margin?

Diebold Nixdorf (DBD) had a gross margin of 25.3% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Diebold Nixdorf's operating margin?

Diebold Nixdorf (DBD) had an operating margin of 6.4% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Diebold Nixdorf's net profit margin?

Diebold Nixdorf (DBD) had a net profit margin of 2.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Diebold Nixdorf's return on equity (ROE)?

Diebold Nixdorf (DBD) has a return on equity of 8.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Diebold Nixdorf's operating cash flow?

Diebold Nixdorf (DBD) generated $300.7M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Diebold Nixdorf's total assets?

Diebold Nixdorf (DBD) had $3.9B in total assets as of fiscal year 2025, including both current and long-term assets.

How much does Diebold Nixdorf spend on research and development?

Diebold Nixdorf (DBD) invested $86.7M in research and development during fiscal year 2025.

Does Diebold Nixdorf buy back shares?

Yes, Diebold Nixdorf (DBD) spent $130.7M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Diebold Nixdorf have outstanding?

Diebold Nixdorf (DBD) had 35M shares outstanding as of fiscal year 2025.

What is Diebold Nixdorf's current ratio?

Diebold Nixdorf (DBD) had a current ratio of 1.30 as of fiscal year 2025, which is considered adequate.

What is Diebold Nixdorf's debt-to-equity ratio?

Diebold Nixdorf (DBD) had a debt-to-equity ratio of 0.85 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Diebold Nixdorf's return on assets (ROA)?

Diebold Nixdorf (DBD) had a return on assets of 2.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Diebold Nixdorf's Altman Z-Score?

Diebold Nixdorf (DBD) has an Altman Z-Score of 1.94, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Diebold Nixdorf's Piotroski F-Score?

Diebold Nixdorf (DBD) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Diebold Nixdorf's earnings high quality?

Diebold Nixdorf (DBD) has an earnings quality ratio of 3.18x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Diebold Nixdorf cover its interest payments?

Diebold Nixdorf (DBD) has an interest coverage ratio of 3.2x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Diebold Nixdorf?

Diebold Nixdorf (DBD) scores 33 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.